Mitoxantrone in progressive multiple sclerosis (MS): a placebo-controlled, randomized, observer-blind European phase III multicenter study-clinical results (Abstract OR 207). - Hartung,H.P.; Gonsette R,null. (Multiple Sclerosis, 1998)